Sarepta Therapeutics Inc (SRPT)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 1,901,980 | 1,243,340 | 933,013 | 701,887 | 540,099 |
| Total assets | US$ in thousands | 3,963,170 | 3,264,580 | 3,128,370 | 3,147,970 | 2,984,720 |
| Total asset turnover | 0.48 | 0.38 | 0.30 | 0.22 | 0.18 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $1,901,980K ÷ $3,963,170K
= 0.48
The total asset turnover ratio for Sarepta Therapeutics Inc has shown a consistent increasing trend over the years, indicating improved efficiency in generating revenue from its total assets.
In 2020, the total asset turnover was 0.18, which means that for every dollar of total assets, the company generated $0.18 in sales.
By the end of 2021, the ratio increased to 0.22, suggesting a higher utilization of assets to generate revenue.
This trend continued with the ratio reaching 0.30 by December 31, 2022, demonstrating a further enhancement in asset efficiency.
The total asset turnover ratio for December 31, 2023, stood at 0.38, reflecting the company's ability to generate $0.38 in sales for every dollar of total assets.
As of December 31, 2024, the total asset turnover ratio improved to 0.48, indicating that Sarepta Therapeutics Inc efficiently generated $0.48 in sales for every dollar of total assets.
Overall, the increasing trend in the total asset turnover ratio reflects the company's improving efficiency in utilizing its assets to generate sales over the years.
Peer comparison
Dec 31, 2024